These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 31184607)

  • 1. [A Group of Hypermethylated miRNA Genes in Breast Cancer and Their Diagnostic Potential].
    Filippova EA; Loginov VI; Pronina IV; Khodyrev DS; Burdennyya AM; Kazubskaya TP; Braga EA
    Mol Biol (Mosk); 2019; 53(3):421-429. PubMed ID: 31184607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.
    Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marker Systems Based on MicroRNA Gene Methylation for the Diagnosis of Stage I-II Breast Cancer.
    Braga EA; Filippova EA; Loginov VI; Pronina IV; Burdennyi AM; Kazubskaya TP; Fridman MV; Khodyrev DS; Kushlinskii NE
    Bull Exp Biol Med; 2019 Dec; 168(2):280-284. PubMed ID: 31782000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylated Genes of MicroRNA in Ovarian Carcinoma: Metastasis Prediction Marker Systems.
    Filippova EA; Loginov VI; Burdennyi AM; Braga EA; Pronina IV; Kazubskaya TP; Kushlinskii DN; Utkin DO; Fridman MV; Khodyrev DS; Kushlinskii NE
    Bull Exp Biol Med; 2019 May; 167(1):79-83. PubMed ID: 31177462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Novel miRNA genes hypermethylated in breast cancer].
    Loginov VI; Burdennyy AM; Pronina IV; Khokonova VV; Kurevljov SV; Kazubskaya TP; Kushlinskii NE; Braga EA
    Mol Biol (Mosk); 2016; 50(5):797-802. PubMed ID: 27830681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Value of a Group of MicroRNA Genes Hypermethylated in Ovarian Carcinoma.
    Braga EA; Loginov VI; Filippova EA; Burdennyi AM; Pronina IV; Kazubskaya TP; Khodyrev DS; Utkin DO; Kushlinskii DN; Adamyan LV; Kuslinskii NE
    Bull Exp Biol Med; 2018 Dec; 166(2):253-256. PubMed ID: 30488208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypermethylation of miR-107, miR-130b, miR-203a, miR-1258 Genes Associated with Ovarian Cancer Development and Metastasis].
    Loginov VI; Burdennyy AM; Filippova EA; Pronina IV; Kazubskaya TP; Kushlinsky DN; Ermilova VD; Rykov SV; Khodyrev DS; Braga EA
    Mol Biol (Mosk); 2018; 52(5):801-809. PubMed ID: 30363055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five Hypermethylated MicroRNA Genes as Potential Markers of Ovarian Cancer.
    Braga EA; Loginov VI; Burdennyi AM; Filippova EA; Pronina IV; Kurevlev SV; Kazubskaya TP; Kushlinskii DN; Utkin DO; Ermilova VD; Kushlinskii NE
    Bull Exp Biol Med; 2018 Jan; 164(3):351-355. PubMed ID: 29313235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
    Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ
    Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer.
    Lehmann U; Hasemeier B; Christgen M; Müller M; Römermann D; Länger F; Kreipe H
    J Pathol; 2008 Jan; 214(1):17-24. PubMed ID: 17948228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of miRNA-9 and miRNA-34a as potential biomarkers for diagnosis of breast cancer in Iranian women.
    Orangi E; Motovali-Bashi M
    Gene; 2019 Mar; 687():272-279. PubMed ID: 30468908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and DNA methylation alterations of seven cancer-associated 3p genes and their predicted regulator miRNAs (miR-129-2, miR-9-1) in breast and ovarian cancers.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Kazubskaya TP; Dmitriev AA; Braga EA
    Gene; 2016 Jan; 576(1 Pt 3):483-91. PubMed ID: 26519551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation deregulation of miRNA promoters identifies miR124-2 as a survival biomarker in Breast Cancer in very young women.
    Oltra SS; Peña-Chilet M; Vidal-Tomas V; Flower K; Martinez MT; Alonso E; Burgues O; Lluch A; Flanagan JM; Ribas G
    Sci Rep; 2018 Sep; 8(1):14373. PubMed ID: 30258192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation-Associated Silencing of miR-125a and miR-125b: A Potential Marker in Colorectal Cancer.
    Chen H; Xu Z
    Dis Markers; 2015; 2015():345080. PubMed ID: 26693202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of micrornas in molecular genetic breast cancer subtypes.
    Kolesnikov NN; Veryaskina YA; Titov SE; Rodionov VV; Gening TP; Abakumova TV; Kometova VV; Torosyan MK; Zhimulev IF
    Cancer Treat Res Commun; 2019; 20():100026. PubMed ID: 31255253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Methylation of some miRNA genes is involved in the regulation of their target genes RAR-beta2 and NKIRAS1 expression in lung cancer].
    Khodyrev DS; Pronina IV; Rykov SV; Beresneva EV; Fridman MV; Kazubskaia TP; Loginov VI; Braga ÉA
    Mol Biol (Mosk); 2012; 46(5):773-85. PubMed ID: 23156677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between miR-34 dysregulation and distant metastases formation in lung adenocarcinoma.
    Daugaard I; Knudsen A; Kjeldsen TE; Hager H; Hansen LL
    Exp Mol Pathol; 2017 Jun; 102(3):484-491. PubMed ID: 28512015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of microRNAs in Nipple Discharge as Potential Diagnostic Biomarkers for Breast Cancer.
    Zhang K; Zhao S; Wang Q; Yang HS; Zhu J; Ma R
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S536-44. PubMed ID: 25976861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant miRNAs expressed in HER-2 negative breast cancers patient.
    Braicu C; Raduly L; Morar-Bolba G; Cojocneanu R; Jurj A; Pop LA; Pileczki V; Ciocan C; Moldovan A; Irimie A; Eniu A; Achimas-Cadariu P; Paradiso A; Berindan-Neagoe I
    J Exp Clin Cancer Res; 2018 Oct; 37(1):257. PubMed ID: 30342533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.